Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeliveroo Regulatory News (ROO)

Share Price Information for Deliveroo (ROO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 139.70
Bid: 139.40
Ask: 139.70
Change: 1.90 (1.38%)
Spread: 0.30 (0.215%)
Open: 136.00
High: 141.40
Low: 136.00
Prev. Close: 137.80
ROO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

31 Mar 2021 07:00

RNS Number : 0398U
Goldman Sachs International
31 March 2021
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Deliveroo Holdings plc

Stabilisation Notice

31 March 2021

Goldman Sachs International hereby gives notice that the entity undertaking stabilisation (the "Stabilisation Manager" named below and its affiliates) may stabilise the offer of the following securities in accordance with Regulation (EU) No 596/2014 (Market Abuse Regulation) and Commission Delegated Regulation (EU) 2016/1052, in each case as it forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018. Stabilisation transactions aim at supporting the market price of the Securities during the Stabilisation Period. Stabilisation may not necessarily occur and it may cease at any time.

The securities:

Issuer:

Deliveroo Holdings plc

Securities:

Class A Ordinary registered shares ("ORDs" or "Class A Ordinary Shares") of the Issuer (ISIN: GB00BNC5T391)

Offering size:

384,615,384 Class A Ordinary Shares (excluding the over-allotment option)

Offer Price:

390 pence per Offer Share

Stabilisation:

Stabilisation Manager (and central point within the meaning of Commission Delegated Regulation (EU) 2016/1052):

Goldman Sachs International, Plumtree Court, 25 Shoe Lane, London EC4A 4AU

Contact: Luke Hicks; telephone: +44 (0)20 7552 1169

Beginning of the Stabilisation Period:

31 March 2021

Stabilisation Period to end no later than:

30 April 2021

Trading venue where stabilisation may be undertaken:

London Stock Exchange ("LSE"), BATS, Chi-X

Over-allotment & Greenshoe Option:

Terms:

In connection with the offering (the "Offer"), the Stabilisation Manager, or any of its agents, may (but will be under no obligation to), to the extent permitted by applicable law, over-allot Class A Ordinary Shares sold in the Offer (the "Offer Shares") or effect other stabilisation transactions with a view to supporting the market price of the Class A Ordinary Shares at a level higher than that which might otherwise prevail in the open market pursuant to an over-allotment option granted to it in connection with the Offer (the "Over-allotment Option"). The Stabilisation Manager is not required to enter into such transactions and such transactions may be effected on any securities market, over-the-counter market, stock exchange or otherwise and may be undertaken at any time during the period commencing on the date of the commencement of conditional dealings in the Class A Ordinary Shares on the London Stock Exchange and ending no later than 30 calendar days thereafter. However, there will be no obligation on the Stabilisation Manager or any of its agents to effect stabilising transactions and there is no assurance that stabilising transactions will be undertaken. Such stabilisation, if commenced, may be discontinued at any time without prior notice. In no event will measures be taken to stabilise the market price of the Class A Ordinary Shares above the offer price of 390 pence per Offer Share. Except as required by law or regulation, neither the Stabilisation Manager nor any of its agents intends to disclose the extent of any over-allotments made and/or stabilisation transactions conducted in relation to the Offer.

In connection with the Offer, the Stabilisation Manager may, for stabilisation purposes, over-allot Class A Ordinary Shares up to a maximum of 10% of the total number of Offer Shares comprised in the Offer (the "Over-allotment Shares").

The Over-allotment Option is exercisable in whole or in part, upon notice by the Stabilisation Manager, at any time on or before the 30th calendar day after the commencement of conditional dealings in the Class A Ordinary Shares on the London Stock Exchange. Any Over-allotment Shares made available pursuant to the over-allotment arrangement will rank pari passu in all respects with all other Offer Shares, including for all dividends and other distributions declared, made or paid on the Offer Shares, will be purchased on the same terms and conditions as the Offer Shares being issued or sold in the Offer and will form a single class for all purposes with the other Class A Ordinary Shares.

Number of shares covered by Over-allotment Option:

38,461,538 Class A Ordinary Shares

Duration:

This option may be executed at any time during the Stabilisation Period.

 

 

 

Disclaimer

 

In connection with the offer of the above securities, the Stabilisation Manager or any of its agents may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager or any of its agents will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

 

This announcement is for information only and does not constitute an offer or invitation to underwrite, subscribe for or otherwise acquire or dispose of any securities or investment advice in any jurisdiction in which such an offer or solicitation is unlawful, including without limitation, the United States, Australia, Canada, or Japan. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

 

This announcement and the information contained herein, is not an offer of securities for sale in, and is not for transmission to or publication, distribution or release, directly or indirectly, in the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"). The securities being offered have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under any applicable securities laws of any state or other jurisdiction of the United States and may not be offered, sold, resold, transferred or delivered, directly or indirectly, in the United States unless registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, such registration requirements and in accordance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the securities discussed herein is being made in the United States.

 

In the United Kingdom, this announcement is being distributed only to, and is directed only at, persons who: (A) (i) are "investment professionals" specified in Article 19(5) of the Financial Services and Markets Act (Financial Promotion) Order 2005 (the "Order") and/or (ii) fall within Article 49(2)(a) to (d) of the Order (and only where the conditions contained in those Articles have been, or will at the relevant time be, satisfied); and (B) are "qualified investors" within the meaning of Article 2 of the Prospectus Regulation (Regulation (EU) 2017/1129) as it forms part of retained EU law as defined in the EU (Withdrawal) Act 2018 (all such persons together being referred to as "Relevant Persons"). In the European Economic Area (the "EEA"), this announcement is addressed only to and directed only at, persons in member states who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (Regulation ((EU) 2017/1129) ("Qualified Investors"). This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not Relevant Persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to: (i) in the United Kingdom, Relevant Persons; and (ii) in any member state of the EEA, Qualified Investors, and will be engaged in only with such persons.

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAWPUCCWUPGPPU
Date   Source Headline
29th May 202411:00 amRNSHolding(s) in Company
28th May 202411:00 amRNSEBT Share Purchase Programme
23rd May 20243:30 pmRNSBoard Committee Changes
23rd May 20243:00 pmRNSPublication of AGM Results
20th May 202411:00 amRNSEBT Share Purchase Programme
13th May 202411:00 amRNSEBT Share Purchase Programme
7th May 202411:00 amRNSEBT Share Purchase Programme
30th Apr 202410:00 amRNSTotal Voting Rights
29th Apr 202411:00 amRNSEBT Share Purchase Programme
22nd Apr 20245:16 pmRNSDirector/PDMR Shareholding
22nd Apr 202411:00 amRNSEBT Share Purchase Programme
18th Apr 20247:00 amRNSQ1 2024 Trading Update
17th Apr 202410:00 amRNSNotice of AGM
16th Apr 20241:00 pmRNSHolding(s) in Company
15th Apr 202411:00 amRNSEBT Share Purchase Programme
12th Apr 20245:13 pmRNSHolding(s) in Company
11th Apr 202411:07 amRNSBlock listing Interim Review
10th Apr 202411:00 amRNSHolding(s) in Company
9th Apr 202411:00 amRNSHolding(s) in Company
9th Apr 202411:00 amRNSHolding(s) in Company
8th Apr 202411:00 amRNSEBT Share Purchase Programme
8th Apr 20247:05 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSConversion of B Shares, Share Redesignation & TVR
28th Mar 202411:00 amRNSTotal Voting Rights
27th Mar 20247:00 amRNSEBT Share Purchase Programme
25th Mar 20241:00 pmRNSDirector/PDMR Shareholding
21st Mar 202411:45 amRNSAnnual Financial Report
14th Mar 20247:00 amRNSDeliveroo FY2023 Preliminary Results
4th Mar 202411:00 amRNSHolding(s) in Company
29th Feb 202411:00 amRNSHolding(s) in Company
29th Feb 202410:00 amRNSTotal Voting Rights
2nd Feb 202411:45 amRNSHolding(s) in Company
2nd Feb 202411:30 amRNSHolding(s) in Company
30th Jan 20244:15 pmRNSHolding(s) in Company
22nd Jan 20243:30 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSQ4 2023 Trading Update
15th Jan 20243:00 pmRNSHolding(s) in Company
2nd Jan 202410:00 amRNSTotal Voting Rights
13th Dec 202311:00 amRNSHolding(s) in Company
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 202312:00 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 202311:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSCapital Markets Event
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.